AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 4908341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 30816982 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Support Program (MSP)
Number of subjects: 98
Study 30816982 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 98
Study 28710219 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 316
Study 28710219 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 316
Study 25306925 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (n = 33)
Number of subjects: 68
Study 25306925 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 35)
Number of subjects: 68
Study 23685830 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin spray (10 mL)
Number of subjects: 95
Study 23685830 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar sealer (radiofrequency energy)
Number of subjects: 95
Study 23685830 — intervention group
Group type: COMPARATOR
Intervention: Standard electrocautery (control)
Number of subjects: 95
Study 21864624 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix M™ adjuvanted virosomal H5N1 vaccine (1.5, 7.5, or 30 μg HA with 50 μg Matrix M™)
Number of subjects: 60
Study 21864624 — intervention group
Group type: EXPERIMENTAL
Intervention: Virosomal H5N1 vaccine alone (30 μg HA)
Number of subjects: 60
Study 19704393 — intervention group
Group type: COMPARATOR
Intervention: Male partners of teen girls (15-19 years)
Number of subjects: 514
Study 17670909 — intervention group
Group type: COMPARATOR
Intervention: Postnatal support
Number of subjects: 450
Study 17670909 — intervention group
Group type: COMPARATOR
Intervention: Antenatal education
Number of subjects: 450
Study 15020026 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation or reduction programme
Number of subjects: 297
Study 15020026 — intervention group
Group type: EXPERIMENTAL
Intervention: Both smoking cessation and breast‐feeding education and support programmes
Number of subjects: 297
Study 15020026 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 297
Study 11331165 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micro g/kg neostigmine
Number of subjects: 45
Study 11331165 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micro g/kg neostigmine
Number of subjects: 45
Study 11331165 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 45
Study 9060525 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation at weeks 1 to 4 (Group I)
Number of subjects: 103
Study 9060525 — intervention group
Group type: COMPARATOR
Intervention: Delayed chemoradiation at weeks 6 to 9 (Group II)
Number of subjects: 103
Study 8359923 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR live oral cholera vaccine (5 x 10^9 CFU)
Number of subjects: 247
Study 8359923 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR live oral cholera vaccine (5 x 10^8 CFU)
Number of subjects: 247
Study 8359923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 3772096 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular alcohol consumption (0.8 g/kg per day)
Number of subjects: 10
Study 3772096 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-free control period
Number of subjects: 10
Study 3772096 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular alcohol consumption
Number of subjects: 10
Study 31854112 — intervention group
Group type: EXPERIMENTAL
Intervention: One-month dual anti-platelet therapy (DAPT) with ticagrelor and aspirin followed by 23-month ticagrelor monotherapy
Number of subjects: 6693
Study 31854112 — intervention group
Group type: COMPARATOR
Intervention: Standard 12-month DAPT followed by 12-month aspirin monotherapy
Number of subjects: 6693
Study 31854112 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (ticagrelor monotherapy after DAPT)
Number of subjects: 6693
Study 31854112 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (standard DAPT followed by aspirin)
Number of subjects: 6693
Study 29642062 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant
Number of subjects: 71
Study 27130717 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) applied by a physiotherapist on postoperative day 1
Number of subjects: 92
Study 27130717 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT)
Number of subjects: 92
Study 27130717 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (usual dressing tape)
Number of subjects: 92
Study 24819579 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention (5-month program facilitated by high school mentors)
Number of subjects: 151
Study 24819579 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard curriculum)
Number of subjects: 151
Study 23106929 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety symptoms
Number of subjects: 175
Study 23106929 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression symptoms
Number of subjects: 175
Study 23106929 — intervention group
Group type: COMPARATOR
Intervention: Neither anxiety nor depression symptoms
Number of subjects: 175
Study 23106929 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medication use
Number of subjects: 175
Study 20192867 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform switching
Number of subjects: 18
Study 20192867 — intervention group
Group type: COMPARATOR
Intervention: Traditional approach
Number of subjects: 18
Study 18400948 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated single-strand tendons in the old age group
Number of subjects: 126
Study 18400948 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonirradiated double-strand tendons in the old age group
Number of subjects: 126
Study 18400948 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-strand irradiated old tendons
Number of subjects: 126
Study 18400948 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated young tendons and old double-strand tendons
Number of subjects: 126
Study 18400948 — intervention group
Group type: COMPARATOR
Intervention: Nonirradiated tendons
Number of subjects: 126
Study 16095144 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate-salmeterol (100/50 microg) twice daily for 12 weeks
Number of subjects: 203
Study 16095144 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (100 microg) alone twice daily for 12 weeks
Number of subjects: 203
Study 16095144 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate-salmeterol (100/50 microg) and Fluticasone propionate (100 microg)
Number of subjects: 203
Study 12498545 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral condition (22 degrees C)
Number of subjects: 12
Study 12498545 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot condition (35 degrees C)
Number of subjects: 12
Study 12498545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold condition (5 degrees C)
Number of subjects: 12
Study 12498545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol concentration and perceived exertion
Number of subjects: 12
Study 12498545 — intervention group
Group type: EXPERIMENTAL
Intervention: Body temperatures
Number of subjects: 12
Study 10490110 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) and UV-A combination treatment
Number of subjects: 135
Study 10490110 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) alone
Number of subjects: 135
Study 10490110 — intervention group
Group type: COMPARATOR
Intervention: UV-A alone
Number of subjects: 135
Study 10490110 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of FP and UV-A
Number of subjects: 135
Study 7472588 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Support Device (PSD)
Number of subjects: 190
Study 7472588 — intervention group
Group type: COMPARATOR
Intervention: Control (no PSD)
Number of subjects: 190
Study 1638252 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers (≥20 cigarettes/day)
Number of subjects: 228
Study 1638252 — intervention group
Group type: COMPARATOR
Intervention: Current smokers (<20 cigarettes/day)
Number of subjects: 228
Study 1638252 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with more than one sexual partner
Number of subjects: 228
Study 1638252 — intervention group
Group type: COMPARATOR
Intervention: Women with only one sexual partner
Number of subjects: 228
Study 1638252 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of oral contraceptives
Number of subjects: 228
Study 1638252 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 228
Study 1638252 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower risk groups
Number of subjects: 228
Study 6736276 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiothixene
Number of subjects: 19
Study 31409300 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced preoperative education about continuous femoral nerve block with patient-controlled analgesia (PCA)
Number of subjects: 60
Study 31409300 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard education)
Number of subjects: 60
Study 30486843 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) plus Usual Care (UC)
Number of subjects: 90
Study 30486843 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 90
Study 26951772 — intervention group
Group type: EXPERIMENTAL
Intervention: I-BiT DVD footage
Number of subjects: 75
Study 26951772 — intervention group
Group type: EXPERIMENTAL
Intervention: I-BiT modified shooter game (Nux)
Number of subjects: 75
Study 26951772 — intervention group
Group type: COMPARATOR
Intervention: Non-I-BiT games (non-interactive binocular treatment)
Number of subjects: 75
Study 24732630 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal occult blood test (FOBT)
Number of subjects: 3195
Study 24732630 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 3195
Study 22639845 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+CTG
Number of subjects: 29
Study 22639845 — intervention group
Group type: COMPARATOR
Intervention: CAF alone
Number of subjects: 29
Study 20737524 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg) plus fluoxetine (20 mg/day)
Number of subjects: 42
Study 20737524 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day) plus placebo
Number of subjects: 42
Study 18799202 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin, 0.4 mg/d
Number of subjects: 139
Study 18799202 — intervention group
Group type: COMPARATOR
Intervention: Control (no tamsulosin)
Number of subjects: 139
Study 15817343 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (n = 65)
Number of subjects: 130
Study 15817343 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 65)
Number of subjects: 130
Study 14512671 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense endurance training
Number of subjects: 27
Study 14512671 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 27
Study 10649929 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma Alternate
Number of subjects: 55
Study 10649929 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Multi-Purpose (SMP)
Number of subjects: 55
Study 10649929 — intervention group
Group type: COMPARATOR
Intervention: Health-Dent Desensitizer
Number of subjects: 55
Study 10649929 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer (rescue treatment)
Number of subjects: 55
Study 8727805 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin
Number of subjects: 469
Study 8727805 — intervention group
Group type: COMPARATOR
Intervention: BCG-Tice
Number of subjects: 469
Study 8727805 — intervention group
Group type: COMPARATOR
Intervention: BCG-RIVM
Number of subjects: 469
Study 1829030 — intervention group
Group type: EXPERIMENTAL
Intervention: gestodene (75 micrograms) + ethinyl oestradiol (30 micrograms)
Number of subjects: 20
Study 1829030 — intervention group
Group type: EXPERIMENTAL
Intervention: desogestrel (150 micrograms) + ethinyl oestradiol (30 micrograms)
Number of subjects: 20
Study 6852987 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 10
Study 6852987 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 10
Study 6852987 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 200 mg
Number of subjects: 10
Study 6852987 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 25 mg
Number of subjects: 10
Study 30614168 — intervention group
Group type: EXPERIMENTAL
Intervention: AH-plus with continuous wave of condensation technique (CTW)
Number of subjects: 43
Study 30614168 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoSeal MTA with single-cone technique (SCT)
Number of subjects: 43
Study 30614168 — intervention group
Group type: COMPARATOR
Intervention: MTA Fillapex with single-cone technique (SCT)
Number of subjects: 43
Study 30614168 — intervention group
Group type: COMPARATOR
Intervention: EndoSequence BC Sealer with single-cone technique (SCT)
Number of subjects: 43
Study 27957678 — intervention group
Group type: EXPERIMENTAL
Intervention: RPI25 (25% replacement of SPI)
Number of subjects: 180
Study 27957678 — intervention group
Group type: EXPERIMENTAL
Intervention: RPI50 (50% replacement of SPI)
Number of subjects: 180
Study 27957678 — intervention group
Group type: EXPERIMENTAL
Intervention: RPI75 (75% replacement of SPI)
Number of subjects: 180
Study 27957678 — intervention group
Group type: EXPERIMENTAL
Intervention: RPI100 (100% replacement of SPI)
Number of subjects: 180
Study 27957678 — intervention group
Group type: COMPARATOR
Intervention: Control (Soybean protein isolate)
Number of subjects: 180
Study 25194621 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair stand exercise (12 weeks, 3 sessions/week)
Number of subjects: 27
Study 25194621 — intervention group
Group type: COMPARATOR
Intervention: Control exercise (stretch, 1 session/week)
Number of subjects: 27
Study 25194621 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair stand exercise
Number of subjects: 27
Study 24651278 — intervention group
Group type: EXPERIMENTAL
Intervention: 33 °C for 24 hours
Number of subjects: 939
Study 24651278 — intervention group
Group type: COMPARATOR
Intervention: 36 °C for 24 hours
Number of subjects: 939
Study 23072081 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and Tuina therapy (group A)
Number of subjects: 64
Study 23072081 — intervention group
Group type: COMPARATOR
Intervention: Calcium Carbonate D3 (group B)
Number of subjects: 64
Study 19775918 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaconda AAA Stent Graft System
Number of subjects: 61
Study 17880325 — intervention group
Group type: EXPERIMENTAL
Intervention: NSTE ACS patients
Number of subjects: 26466
Study 17880325 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 26466
Study 17880325 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-risk group
Number of subjects: 26466
Study 17880325 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 26466
Study 15291377 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan (2.5-80 mg once daily)
Number of subjects: 792
Study 15291377 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan (with or without hydrochlorothiazide)
Number of subjects: 792
Study 15291377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792
Study 11939868 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned cesarean delivery
Number of subjects: 1596
Study 11939868 — intervention group
Group type: COMPARATOR
Intervention: Planned vaginal delivery
Number of subjects: 1596
Study 9443715 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 133
Study 9443715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 7621039 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic thermography
Number of subjects: 44
Study 2006597 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 81
Study 2006597 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 81
Study 2006597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketobemidone
Number of subjects: 81
Study 2006597 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (morphine, meperidine, ketobemidone)
Number of subjects: 81
Study 6754485 — intervention group
Group type: EXPERIMENTAL
Intervention: khellin, orally administered for 4 months with subsequent exposure to natural sunlight
Number of subjects: 30
Study 6754485 — intervention group
Group type: COMPARATOR
Intervention: control group (30 subjects)
Number of subjects: 30
Study 31597484 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon juice
Number of subjects: 27
Study 31597484 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar water
Number of subjects: 27
Study 31597484 — intervention group
Group type: COMPARATOR
Intervention: Gatorade
Number of subjects: 27
Study 31597484 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 27
Study 31184382 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention delivered by pediatricians or psychologists (n=183)
Number of subjects: 361
Study 31184382 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=178)
Number of subjects: 361
Study 31184382 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 361
Study 28923880 — intervention group
Group type: EXPERIMENTAL
Intervention: High sugar diet (26% total energy)
Number of subjects: 25
Study 28923880 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sugar diet (6% total energy)
Number of subjects: 25
Study 25730895 — intervention group
Group type: EXPERIMENTAL
Intervention: Action planning intervention for engaging in physical activity
Number of subjects: 195
Study 25730895 — intervention group
Group type: EXPERIMENTAL
Intervention: Action planning intervention for limiting or interrupting sedentary behavior
Number of subjects: 195
Study 24996973 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot brushing simulation
Number of subjects: 27
Study 24996973 — intervention group
Group type: COMPARATOR
Intervention: Clinical brushing techniques (horizontal, rotating, vertical)
Number of subjects: 27
Study 22430972 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir plus adefovir (ETV+ADV)
Number of subjects: 90
Study 22430972 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine plus adefovir (LAM+ADV)
Number of subjects: 90
Study 19492933 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric nasogastric feeds within 48 h of intubation
Number of subjects: 59
Study 19492933 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fluids
Number of subjects: 59
Study 17454965 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit measure of loneliness
Number of subjects: 25
Study 17454965 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional support indices of social support
Number of subjects: 25
Study 17454965 — intervention group
Group type: COMPARATOR
Intervention: Structural support
Number of subjects: 25
Study 15206964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure haemorrhoidectomy
Number of subjects: 30
Study 15206964 — intervention group
Group type: COMPARATOR
Intervention: Open haemorrhoidectomy
Number of subjects: 30
Study 12150168 — intervention group
Group type: EXPERIMENTAL
Intervention: Heptavalent pneumococcal conjugate vaccine
Number of subjects: 36471
Study 12150168 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36471
Study 9718904 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-starch ORS
Number of subjects: 63
Study 9718904 — intervention group
Group type: COMPARATOR
Intervention: Glucose-based ORS
Number of subjects: 63
Study 7806421 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume plasmapheresis
Number of subjects: 18
Study 2503865 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral glucose by nasojejunal tube
Number of subjects: 20
Study 2503865 — intervention group
Group type: COMPARATOR
Intervention: Parenteral glucose by intravenous infusion
Number of subjects: 20
Study 339865 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticrynafen
Number of subjects: 12
Study 339865 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 12
Study 30900550 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including a webinar, monthly reports of general practice-specific data for antibiotic prescribing, and decision support tools.
Number of subjects: 582675
Study 30900550 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 582675
Study 30900550 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention for adults aged 15-84 years.
Number of subjects: 582675
Study 30900550 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety outcomes analysis from trial data.
Number of subjects: 582675
Study 30900550 — intervention group
Group type: COMPARATOR
Intervention: Cohort study in non-trial practices.
Number of subjects: 582675
Study 27577608 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBT) training, six two-hour sessions for three weeks
Number of subjects: 88
Study 27577608 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 88
Study 25826620 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 555
Study 25826620 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive activity
Number of subjects: 555
Study 25826620 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated cognitive and physical exercise (CP)
Number of subjects: 555
Study 25826620 — intervention group
Group type: COMPARATOR
Intervention: Social activity (active control)
Number of subjects: 555
Study 23975232 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction to walk 'as fast as possible'
Number of subjects: 24
Study 23975232 — intervention group
Group type: COMPARATOR
Intervention: Standard instruction to walk 'as far as possible'
Number of subjects: 24
Study 23975232 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction to walk 'at your normal pace'
Number of subjects: 24